Confirmed long-term safety and efficacy of prophylactic treatment with BAY 94-9027 in severe haemophilia A: final results of the PROTECT VIII extension study.

Mark T Reding Ingrid Pabinger-FaschingPal Andre HolmeLone PoulsenClaude G NegrierPavani ChalasaniMonika Maas EnriquezMaria WangKarina MeijerMaria Elisa MancusoShadan Lalezari

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2021)

Efficacy and safety of BAY 94-9027 was confirmed, with extension data supporting its use as a long-term treatment option for patients with haemophilia A.

Keyphrases

machine learning
big data
artificial intelligence
replacement therapy
drug induced